California State Teachers Retirement System Atreca, Inc. Transaction History

California State Teachers Retirement System

$80.4 Billion
Q2 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $17,776 - $37,033	-11,395 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $4,250 - $13,728	-2,640 Reduced 18.81%	11,395 $36,000
Q4 2021 Feb 15, 2022	SELL	$2.87 - $6.29 $58,301 - $127,775	-20,314 Reduced 59.14%	14,035 $43,000
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $7,011 - $12,951	-1,428 Reduced 3.99%	34,349 $214,000
Q2 2021 Aug 16, 2021	SELL	$7.82 - $13.8 $60,941 - $107,543	-7,793 Reduced 17.89%	35,777 $305,000
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $12,482 - $16,372	958 Added 2.25%	43,570 $704,000
Q3 2020 Nov 17, 2020	BUY	$12.67 - $23.19 $133,415 - $244,190	10,530 Added 32.82%	42,612 $595,000
Q2 2020 Aug 17, 2020	BUY	$12.52 - $23.45 $73,742 - $138,120	5,890 Added 22.49%	32,082 $683,000
Q1 2020 May 13, 2020	BUY	$11.4 - $27.28 $182,958 - $437,816	16,049 Added 158.23%	26,192 $433,000
Q3 2019 Nov 15, 2019	BUY	$10.42 - $22.04 $105,690 - $223,551	10,143 New	10,143 $124,000

Others Institutions Holding BCEL

# of Institutions

Shares Held

30.6K

Call Options Held

Put Options Held

View Full List

About Atreca, Inc.

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

More about BCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account